Home › Non-Small Cell Lung Cancer › California › San Bernardino

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa San Bernardino, CA

9 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Bernardino (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3

Loma Linda University Medical Center, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Nagre-recruitPhase 3

Veterans Affairs Loma Linda Healthcare System, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06498635

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Nagre-recruitPhase 3

Local Institution - 0682, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06875310

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Research Site, Loma Linda · 4 mi ang layo
Research Site, Redlands · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06692738

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Nagre-recruitPhase 3

Research Site, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07291037

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Loma Linda University Medical Center, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

Loma Linda University Medical Center, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3

Loma Linda University Medical Center, Loma Linda · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Nagre-recruitPhase 1/2

Emad Ibrahim MD Inc, Redlands · 7 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 24, 2025 · NCT06228326

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa San Bernardino

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.